Work

Abstract PS2-07-01: Cemiplimab in High-risk or Locally Advanced Luminal and Triple Negative Breast Cancer (CemiHALT)

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps2-07-01

Authors: L. N. Chaudhary, H. Abid, J. M. Jorns, A. Szabo, Y. Sun, S. Kamaraju, Y. Cheng, A. Kong, T. W. Yen, C. Patten, C. S. Cortina, E. Weil, I. Chervoneva, C. R. Chitambar, H. Rui

Institutions: Medical College of Wisconsin, Thomas Jefferson University, Medical College of Wisconsin Cancer Center

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129786821

Cites:

Cited by:

Related to: